If Chinese approval doesn't arrive by COB today (if Chinese wants to debiberately delay to shake the tree one last minute), EOC will have to apply for deferral of 2nd court hearing.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status